Home » Resources / Publications & Posters / Poster: Preclinical Parkinson's Disease - Improving Drug Discovery Using Brain Oscillations as Translational Biomarkers
In this Poster, we investigate the use of aberrant cortical oscillations as translational biomarkers for Parkinson’s Disease Drug development and evaluate the effect of acute (L-Dopa, Apomorphine) and chronic (L-Dopa) treatments on both EEG oscillations and Abnormal Involuntary Movements (AIMs) in the 6-OHDA model.